chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Since July, I have had hip pain when I walk, and it radiates down my legs and affects my knees/lower back. I have not been able to exercise at all. Sitting and standing also hurt. I went to the doctor also for some stomach stuff and I was bleeding after sex. They did a transvaginal US and found a small cyst but nothing else. Within 3 weeks I had a UTI, yeast infection and bacterial infection. I have never had any of those before. I was put on antibiotics and for the most part things cleared up. However, I am still bleeding after sex. They also checked the placement of my IUD, but it was fine. For the body pain, I have received treatment for my hips, and I am taking steroids. I am also in physical therapy, but it is not really helping. I also have had an increase in headaches and migraines.
PATIENT CAME IN ON 12/28/2019 WITH A RASH ON ARM WHERE THE INJECTION SITE WAS. PATIENT WAS ADVISED TO GET CHECKED OUT FROM A PHYSICIAN.
Temp 101, soft spot full and swollen, spinal tap done to r/o meningitis admitted for observation.
Severe joint and muscle pain through out entire body.  Barely able to walk and stand up. Feeling not well and nauseous. Also redness and severe pain in left shoulder at injection site.
Started fever 2 days p/Fluogen given; t105 x 4 days; pt to ER adm for 1 day; IV's given PMD advised no flu vax again;
Subsequent to receiving one dose of varicella virus vaccine live, the pt developed varicella lesions from head to toe. There were approximately 50 lesions, a temperature of 100.1F, left otitis media and impetigo secondary to varicella lesions. The pt sought unspecified medical attention. On 11/25/99, the pt recovered.
Patient stated she got the vaccine on Friday 4/23 @3pm and around 8pm she started feeling fatigued, chills, sweaty, body aches. No fever, sob, or chest pain. Patient stated she took Tylenol q8hrs. As of 4/26/21 11:53pm patient still feels fatigued and body aches, dehydrated. Last time pt took tylenol was on 4/26/21 @11:30am.  Advised patient to continue with the tylenol or she can take ibuprofen. Also advised to stay hydrated with gatorade/water.
Fever(99.9); body aches; Chills; nausea; Lightheadedness; Headache; Headache, red, raised, tender, hot injection site; Headache, red, raised, tender, hot injection site; Headache, red, raised, tender, hot injection site; hot injection site; This is a spontaneous report from a contactable other healthcare professional, the patient. A 35-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 02Apr2021 at 14:00 (at the age of 35-years-old), as a single dose for COVID-19 immunisation. Medical history included COVID-19 on an unknown date. Concomitant medications included ketoprofen (MANUFACTURER UNKNOWN), fexofenadine hydrochloride (ALLEGRA), fluticasone propionate (FLONASE), multivitamin (MANUFACTURER UNKNOWN) and wellness (MANUFACTURER UNKNOWN), all from unknown dates for unknown indications. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received morphine (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date and experienced allergy. On 03Apr2021 at 10:00, the patient experienced fever (99.9), body aches, chills, nausea, lightheadedness, headache, red, raised, tender, hot injection site. On 03Apr2021, the patients body temperature was reported as 99.9 (units unspecified). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of reported events and included treatment with ibuprofen on unknown date. The clinical outcome of the events fever (99.9), body aches, chills, nausea, lightheadedness, headache, red, raised, tender, hot injection site was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
pt recv vax 24JUL96 & that afternoon pt limp & blue face down in stroller;02 sat 93% RA in ER hosp overnoc w/o problems;home 25JUL;now home on apnea monitor
Developed erythema multiforme minor 5-7-08, was also day 9 of amox/clav for otitis media.  No progression to mucosal lesions.
This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not given and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced cough. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 103 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of cough was not reported. This report was non-serious.
Client felt dizzy, faint while sitting in chair 5 minutes after HPV GARDASIL vaccine. Became diaphoretic, pale and stated did not feel well. Took 20 minutes for client to reopen eyes and walked to car with help.
About 24 hours after vaccine she experienced fever, neck pain, arm pain, and extreme fatigue. She experienced these adverse effects for 48 hours after the vaccine.
This case was reported by a nurse via call center representative and described the occurrence of numbness in a 24-year-old female patient who received ENGERIX B (batch number 7S29F, expiry date 24th January 2017). Concomitant products included EXCEDRIN. On 10th February 2015, the patient received the 3rd dose of ENGERIX B (intramuscular) 1 ml. On 10th February 2015 00:05, 5 min after receiving ENGERIX B, the patient experienced numbness and tingling. On an unknown date, the outcome of the numbness and tingling were recovering/resolving. It was unknown if the reporter considered the numbness and tingling to be related to ENGERIX B.
Pt did not have adverse reaction.  Staff accidentally gave pt the 2nd dose 1 week early.
This spontaneous report as received from a medical assistant refers to a patient of unknown age. The patient's medical history and concurrent conditions were not reported. On 02-FEB-2018, the patient was vaccinated with improperly stored M-M-R-II (lot # N010495, expiry date: 31-MAR-2019) reconstituted with improperly stored sterile diluent, lot # M014034, expiry date: 20-NOV-2018. The vaccine was exposed to a temperature of 9 Cº to 25 Cº (8.3Cº) for 1 hour 17 min, on 06-JAN-2018, 9 Cº to 25 Cº (11.5Cº) for 1 hour 59 min on 11-JAN-2018, 9 Cº to 25 Cº (15.6Cº) for 1 hour 33 min on 17-JAN-2018, 9 Cº to 25 Cº (11.9Cº) for 1 hour 2 min on 23-JAN-2018 and 9 Cº to 25 Cº (12.1Cº) for 1 hour on 30-JAN-2018. There was no previous temperature excursion. The call was because of a data logger. No adverse effects reported. The outcome of the event was unknown. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1802USA004616: US-009507513-1802USA004629: US-009507513-1802USA004629: US-009507513-1802USA004636: US-009507513-1802USA004641: US-009507513-1802USA004647: US-009507513-1802USA004652: 1802USA004654: Original Case: 1802USA002182: US-009507513-1802USA004654: US-009507513-1802USA004658: US-009507513-1802USA004663: US-009507513-1802USA004671: US-009507513-1802USA004673: US-009507513-1802USA002182: US-009507513-1802USA004692.
Upon arrival to picking child up from my mothers house. My son complained of left arm pain in the injection site of the vaccine. Upon assessment there was a red warm to the touch swollen rash in the same location. Son has no fever at this time 24 hrs past vaccine. Will reassess tomorrow at the same time to see if worsening or if symptoms resolve.
Information has been received from a 23 year old female with possible penicillin allergy who on approximately 06-AUG-2008 (about six weeks ago) was vaccinated with the second dose of GARDASIL. There was no concomitant medication. The patient reported that since second dose was given on approximately 06-AUG-2008, she had 3 cases of seizures (last episode happened about a week ago, approximately 10-SEP-2008). She mentioned that she only had one incident of seizure activity prior to GARDASIL. The patient stated that she also was experiencing joint pain in her hip as well. At time of reporting, the patient had not recovered. Laboratory tests and studies performed included electroencephalography, cat scan and blood work with unknown results. The patient sought unspecified medical attention. Upon internal review, episodes of seizures were considered to be other important medical events. Additional information is not expected.
Patient reports pain at site, fever, sore throat for 2 days post injection following sores at site, left shoulder pain and decreased strength and range of motion of left arm. Patient has been self treating, alternating TYLENOL or Ibuprofen every 4 hours. Assessed by PAC and referred to a neurologist for evaluation. Have been unable to reach patient per phone to check on status.
I was in bed for about four days/I only got up to go to the bathroom; I was also sick to my stomach; I was so sick; very weak; throw up several times; Bones hurt like she´s got the flu; Flu like symptoms; Dizziness; chills; Nausea; got tired; Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (Bones hurt like she´s got the flu), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (I was in bed for about four days/I only got up to go to the bathroom), ABDOMINAL DISCOMFORT (I was also sick to my stomach), INFLUENZA LIKE ILLNESS (Flu like symptoms) and DIZZINESS (Dizziness) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included DULOXETINE HYDROCHLORIDE (CYMBALTA), SPIRONOLACTONE and CALCIUM for an unknown indication.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Feb-2021, the patient experienced HEADACHE (Headache). On 17-Feb-2021, the patient experienced BONE PAIN (Bones hurt like she´s got the flu), INFLUENZA LIKE ILLNESS (Flu like symptoms), DIZZINESS (Dizziness), CHILLS (chills), NAUSEA (Nausea), FATIGUE (got tired) and PYREXIA (Fever). On an unknown date, the patient experienced LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (I was in bed for about four days/I only got up to go to the bathroom), ABDOMINAL DISCOMFORT (I was also sick to my stomach), ILLNESS (I was so sick), ASTHENIA (very weak) and VOMITING (throw up several times). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at a dose of 1 dosage form. At the time of the report, BONE PAIN (Bones hurt like she´s got the flu), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (I was in bed for about four days/I only got up to go to the bathroom), ABDOMINAL DISCOMFORT (I was also sick to my stomach), INFLUENZA LIKE ILLNESS (Flu like symptoms), DIZZINESS (Dizziness), ILLNESS (I was so sick), ASTHENIA (very weak), CHILLS (chills), NAUSEA (Nausea), FATIGUE (got tired), PYREXIA (Fever) and VOMITING (throw up several times) outcome was unknown and HEADACHE (Headache) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Significant follow up.
Expired vaccine was given. It says EXP 11/2021 on the bottle. I took a picture
4 days after vaccine began getting all over body hives/itchy rash that spread rapidly. Was able to mitigate for 18 hours with over the counter allergy antihistamine medication. Hives came back after allergy medication wore off.
A non-serious spontaneous report of expired FLUMIST administered was received from a health professional concerning a 13-year-old female. Neither the patient's past medical history nor the concomitant medications were reported. The product expired on 29-Nov-2010. The patient received the expired FLUMIST on 23-Dec-2010. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved. 09-Mar-2011: Follow up call was conducted on 09-Mar-2011, no adverse events were reported following administration of the expired FLUMIST.
She began to have quick involuntary rolling of the eyes. Then later she cried her right leg was hurting. She also complained of her head hurting.
Patient was standing and felt dizzy/light headed and fainted in the store roughly 3 minutes after vaccination.
No adverse event reported. Pt given adult pneumovax 23 instead of pediatric pneumococcal (Prevnar) vaccine. Mother notified 05/08/02.
Syncope; headache; body aches; intermittent fevers with flushing/chills; intermittent fevers with flushing/chills; intermittent fevers with flushing/chills; nausea night of 2nd inj and next day; Severe fatigue; joint pain; I felt very ill; akin to the flu; This is a spontaneous report from a contactable nurse(patient). A 53-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on the left arm on 02Feb2021 11:45 AM at a single dose for COVID-19 immunization. Medical history included Crohns disease which is in remission (No immunosuppressants in 5 years) and shellfish sensitivity. The patient received the first  dose of BNT162B2 on 15Jan2021 for covid-19 immunization and experienced syncope. The patient is not pregnant at the time of vaccination. Facility where the most recent COVID-19 vaccine was administered was hospital. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient was not tested for COVID-19. Concomitant medication included duloxetine hydrochloride (CYMBALTA), trazodone, buspirone hydrochloride (BUSPAR), lisdexamfetamine mesilate (VYVANSE) methylfolate and Ma. The patient experienced syncope after injection in Feb2021. A few episodes in 18 hrs, the patient experienced headache, body aches, intermittent fevers with flushing/chills, nausea night of 2nd injection and next day in Feb2021. The patient experienced severe fatigue, joint pain, felt very ill, akin to the flu in Feb2021.No treatment received for the adverse events. The patient underwent lab test included body temperature: intermittent fevers in Feb2021.The outcome of the events was recovering.  Information on the lot/batch number has been requested.; Sender's Comments: A contribution from BNT162B2 to the event syncope is possible based on available information. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate
Starting about 1-2 weeks after the vaccine, I had increased pain throughout your body (above and beyond my baseline).  The pain was in my hands, fingers and shoulders. I also had a radiating pain in both legs on the back but more so on the left leg. I took my prescribed medication which did not alleviate the pain. I went to see the doctor and was given a steroid shot in the lumbar region which help alleviate the pain but I still have pain in the back of my legs and I am having trouble sleeping because the pain will wake me up at night. I was prescribed hydrocodone to add to my medication regimen. Currently I am having tinnitus, dizziness, brain fog, fatigue, change in my taste and phantom smell.
Rash on her chest; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash on her chest) in a 58-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.  The patient's past medical history included No adverse event.  On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced RASH (Rash on her chest). At the time of the report, RASH (Rash on her chest) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Expired vaccine used. A non-serious spontaneous report of administration of expired FLUMIST was received from a nurse in the military concerning a 28-year-old male. Neither medical history nor concomitant medications were reported. On 02-Mar-2009, the patient received expired FLUMIST vaccine. The vaccine had an expiration date of 11-Jan-2009. As of 18-Mar-2009, there was no adverse events associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved. Based on the results of the investigation, the root cause for the medication errors were caused by 1) customers not discarding product from previous season and 2) product expiring during the peak of flu season resulting in some medication errors that occurred shortly after the product expired. Additional information was received on 12-May-2009: Product Complaint Investigation results.
Patient states she noticed a red rash around 4 inches long and oblong around injection site the night after vaccination. It has become hot and itchy over time.
I suffered severe headaches for over one week, right arm extremely sore, chills, fatigue, dizziness, aching body, congestion, runny nose, aching throat, restlessness.
Received annual flu vaccine. At injection site developed large welt, about 2.5 inches in diameter. It's red, itchy, warm to touch, and the area is sore.
Information has been received from the mother of a 6 year old male child with a history of atopic dermatitis who on 14SEP1997 was vaccinated subcutaneously with a 0.5ml dose of varicella virus vaccine live. There was no concomitant medication. On 21JUL2003 the child devloped in excess of 20 lesions on his upper left arm. Pain and itching were associated with the lesions. Unspecified medical attention was sought and on 22JUL2003 the child was diagnosed with shingles and was given cream to treat the lesions. On 25JUL2003 the patient began to recover (also reported as recovering with sequalea). No product quality complaint was involved. On 28JUL2003 a nurse from the physician's office reported that she had not spoken to the mother of the child in a week. She planned to phone the patient's mother. It was also reported that the nurse did not think it was likely that a specimen would be available at this date on this patient. Additional information has been requested.
Information has been received from a health professional concerning a 21 year old female with an allergy to penicillin, who on 14-JAN-2008 was vaccinated with the second dose of Gardasil (lot# 655154/1210U). Concomitant therapy included hormonal contraceptives (unspecified). Within 24 hours the patient developed fever of 102F, headache, nausea, dizziness, muscle aches and low back pain. Treatment oral Benadryl every 4 hours for 48 hours. The patient was recovering, but still had some dizziness, low back pain and is tired. The patient did not experience any adverse effects after her first vaccination. Medical attention was sought. No product quality complaint was involved. Additional information has been requested. This is in follow-up to report(s) previously submitted on 2/14/2008.  Initial and follow-up information has been received from a health professional concerning a 21 year old female with an allergy to PENICILLIN, who on 14-JAN-2008 was vaccinated with the second dose of GARDASIL (lot# 655154/1210U).  Concomitant therapy included hormonal contraceptives (unspecified).  Three days after the vaccination the patient developed body aches, low back pain "hurts all over", fever, and dizziness.  Treatment oral BENADRYL over 4 hours for 4 hours.  The patient recovered from dizziness, low back pain, body aches, hurts all over and fever.  Initial report indicated that patient had headache and nausea and the outcome was unknown.  The patient did not experience any adverse effects after her first vaccination.  Medical attention was sought.  No product quality  compliant was involved.  Additional information has been requested.
On this last Friday I received my first shot. On Sunday I got a lot of groin pain on both sides that interfered with my ability to walk. It still greatly bothers me to the point I can not walk very much at the gym on the treadmill without pain. I regret getting the shot.  When will this groin pain go away? Sincerely,
Information has been received from a school nurse concerning a 10 year old male with no drug reactions or allergies, and with possible learning disability who on 25-AUG-2004 and 30-SEP-2008 was vaccinated with the first and second dose of VARIVAX (Merck) (LOT# not reported), respectively. Now, on 22-MAY-2010 or 23-MAY-2010 the patient experienced itchy rash that may be varicella. There were no diagnostics and labs performed. The patient sought medical attention by telephone call. At this time of reporting, the patient's outcome was unknown. This is the first of three reports concerning the siblings. No further information is available.
When I woke up the day following the vaccine, I noticed a bad rash on my entire right arm. I took some allergy medicine and then had a telehealth appointment with my doctor. After about 3 days it went away. While it was drying up, they became blisters. For the next vaccine I consulted an allergist first, who instructed me to bring an EpiPen and Pepcid AC.
My issue was I developed increased in thirst and in urination that would not stop. I was losing weight. Went to the doctor & they did some testing & it came back I am now a diabetic.
2ND Day about 2pm.  Noticed tongue was swollen about 1 1/2 normal size. Neck also very swollen. Neck Lymph nodes swollen. Did not have difficulty breathing. Tongue swelling went down after 1 hour. Neck swelling went down after 3 days,  Lymph nodes smaller but still are slightly swollen.
The patient stated he noticed red bumps forming on his right arm near the arm pit 10 days after receiving the Shingrix vaccine on 12/27/22. The bumps soon blistered and then crusted over.  The patient stated " it felt like I was been poked by needles on the bumps for a week or so but it has gone away". The patient reported devolping hives on his upper body soon after noticing the bumps which he sought medical attention for on 2/20/23.  The patient was prescribed prednisone and cetirizine. The patient stated he was diagnosed with Shingles.
Syncopal episode immediately after receiving Immunizations. The patients legs were elevated and consciousness was regained shortly after.